Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Oncology Clinical Trial Market: Interventional Segment Witnessed Significant Expansion
2 Rutgers Cancer Institute of New Jersey Chair of Radiation Oncology and Associate Vice Chancellor Named President-Elect of the RSNA Board
3 Imetelstat confers durable transfusion independence in lower-risk myelodysplastic syndrome
4 Update on the Evolution of The US Oncology Network's Clinical Pathways Program
5 ASCO Systemic Therapy Guideline Developed for Advanced HCC
6 Good News for Patients with Brain Metastases
7 3 QUESTIONS ON... What We Know About Treating Older Adults... : Oncology Times
8 The Journal of Clinical Pathways' Excellence in Pathways Award Winners Announced at OCPC 2020
9 Cetuximab Inferior to Cisplatin for Locoregional Control of HNSCC
10 The Evolution Of Biomarker-driven Approaches To Clinical Trials
11 Combination reduces relapse incidence after allogeneic HSCT in high-risk AML subset
12 AI Clinical Decision Support System Impacts Breast Cancer Treatment Decisions
13 ANZUP Mini ASM 2020: New Approaches in Testicular Cancer
14 Preliminary Results Suggest AB-MR Detects Breast Cancers that 3-D Mammograms May Miss
15 Top in hem/onc: Diet and prostate cancer risk, three-drug combination for CLL
16 Addition of SBRT to nivolumab fails to improve outcomes in metastatic head and neck cancer
17 Olema Oncology Appoints Biopharma Industry Veteran Sandra J. Horning, MD, to Board of Directors
18 Commentary Examines What Is Known About BRCA1 Mutations Compared With BRCA2 in Prostate Cancer
19 ANZUP Mini ASM 2020: Multi-Disciplinary Tumor Master Games
20 Verastem Oncology Initiates Phase 2 Registration-Directed Trial of VS-6766 and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer | Small Molecules | News Channels
21 Prognostic model identifies patients with CLL at risk for ibrutinib failure
22 Mary C. Mahoney, MD, Named RSNA President
23 Episode-Based Payment Model Shortens Radiotherapy Courses But Reduces Reimbursements
24 Phase 2 Study Finds Nivolumab-Ipilimumab Combo Shows Activity in Metastatic Uveal Melanoma
25 Manufacturers News : The Hearing Journal
26 Veracyte Announces New Data Published in Journal of Clinical Oncology Suggest the Prosigna Breast Cancer Test's Genomic Underpinning Drives Prognostic Performance
27 ORYZON Publishes Paper in Journal of Clinical Oncology Demonstrating Relevance of Iadademstat in Leukemia
28 Laparoscopic Gastrectomy Is Noninferior to Open Approach in Locally Advanced Gastric Cancer
29 Endomag Secures £15 Million ($20 Million) in Series D Funding
30 Study reveals social needs linked to low health-related quality of life among African American cancer survivors
31 Geron Announces Publication of IMerge Phase 2 Data in Journal of Clinical Oncology
32 Journal of Clinical Oncology Publishes Additional Data from Clovis Oncology's TRITON2 Clinical Trial Evaluating Rubraca® (rucaparib) for the Treatment of mCRPC in Patients with BRCA1/2 Gene Mutations
33 Wolters Kluwer Announces Publishing Collaboration with Leading Oncology Society
34 Treatment Patterns and Outcomes Among US Patients With MCL Treated With Ibrutinib
35 Are More Women Physicians Leaving Medicine as Pandemic Surges?
36 An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic r...
37 Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China
38 Five Prime Therapeutics Announces Publication of the Phase 1 Bemarituzumab Study in the Journal of Clinical Oncology
39 Rushed COVID-19 Papers: 'Interpret With Caution' Says JCO
40 Cardiomyopathy Screenings Low Among Young Cancer Survivors Exposed to Chest Radiation or Anthracyclines
41 A top cancer R&D exec at Genentech joins the exodus, jumping to a marquee China biotech as the new oncology chief, dealmaker
42 Dexamethasone May Make Immune Checkpoint Inhibitors Less Effective for Glioblastoma
43 Single-Dose Radiation Therapy At Time Of Lumpectomy Helps Breast Cancer Patients Overcome Treatment Challenges During Pandemic
44 Long after Merck and Bristol Myers created a multibillion-dollar market, the PD-1 leaders are once again duking it out — this time over a $12B-plus pot
45 Lynparza (olaparib) Receives Health Canada Approval for the Treatment of BRCA or ATM Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
46 Galera Therapeutics Announces Publication of GC4419 Data in the Journal of Clinical Oncology
47 American Society of Clinical Oncology Exclusively Cites myChoice® CDx in New Recommendations for Patients with Advanced Ovarian Cancer
48 2020 Community Oncology Alliance Annual Conference
49 Deciphera Announces Publication of QINLOCK™ (ripretinib) Phase 1 Study Results in Patients with Gastrointestinal Stromal Tumor in Journal of Clinical Oncology
50 Dr. Daniel D. Von Hoff to receive inaugural AACR scientific achievement award
51 Corey Goodman introduces Tallac Therapeutics with a $62M Series A, hoping to fight solid tumors through innate and adaptive immunity
52 Amid Effort to Shrink Cancer Disparities, Authors Say COVID-19 Will Widen Them
53 Melatonin impedes prostate cancer metastasis by suppressing MMP-13 expression.
54 AstraZeneca offloads former crown jewel Crestor as it continues to refocus on oncology drugs
55 How a Couple’s Quest to Cure Cancer Led to the West’s First Covid-19 Vaccine
56 For people with certain BRCA mutations, activating the immune system could be promising treatment
57 More evidence that cellular 'death by iron' could be promising avenue of cancer treatment
58 The FDA spells out 4 reasons why it hates Minerva's NDA ideas — but the biotech is going for it anyway
59 The Lancet Oncology at 20—two decades of influencing the oncology landscape
60 Blood Test Accurately Identifies HPV-related Head and Neck Cancer Recurrence; Prospective Clinical Study Published in Journal of Clinical Oncology
61 New data reinforces Immunoscore clinical utility in localized Colon Cancer
62 Roche turns up the heat on Lilly with another Gavreto approval, elbowing its way into the thyroid cancer space
63 Headed in the Right Direction: Cancer Mortality is Going Down
64 Scientists at Yale School of Medicine design a virus to treat ovarian cancer
65 Risky Breast Lumps; Bone Testing Lags in Prostate Cancer; Cancer Breathalyzer?
66 Veracyte (VCYT) Announces New Data Published in Journal of Clinical Oncology Suggest the Prosigna Breast Cancer Test's Genomic Underpinning Drives Prognostic Performance
67 Combination therapy might improve outcomes in treatment-resistant liver cancer: The drug regorafenib plus an antibody treatment improved survival in mouse models of hepatocellular carcinoma
68 ASCO Updates Systemic Therapy Guideline for Melanoma
69 April 2020
70 Researchers Suggest Breast Cancer Screening in Black Women be Initiated by Age 40
71 Report links recommended physical activity levels to lower risk of seven cancers
72 Agios Pharmaceuticals Inc. (NASDAQ:AGIO) Posts Net TIBSOVO® Revenue Of $31.7 Million IN Q3 2020
73 Supporting Clinical Trials in the Community Oncology Setting
74 Guidelines for Managing Chronic Cancer Pain: More Similar Than Not
75 Veda Giri, MD, on Genetic Testing in Prostate Cancer
76 BriaCell Presents Clinical Findings at 2020 American Society of Clinical Oncology (ASCO) Meeting
77 Consensus Recommendations for Germline Testing in Prostate Cancer
78 BriaCell Announces Presentation and Abstract Publication at 2020 American Society of Clinical Oncology (ASCO) Meeting
79 Guidance issued for genetic testing in prostate cancer
80 ASCO 2020: Clinical Updates | AJMC
81 Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
82 For two years, Ovid spun a Phase II miss as a win. The drug just failed Phase III
83 Large genomics study points the way to future cancer clinical trials
84 New ASCO Clinical Guidelines on Management of Cancer Cachexia
85 Covid‐19: What is the best approach in gynecological oncology patient management during the coronavirus pandemic?
86 Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis.
87 Updates to ASCO's Patient-Centered Oncology Payment Model
88 Care Paths and Oncology Outlook at Cleveland Clinic's Taussig Cancer Institute
89 First Ever Oncology Hospital-At-Home Evaluation Shows Better Outcomes, Lower Costs
90 Geron Corp (GERN) Announces Publication of IMerge Phase 2 Data in Journal of Clinical Oncology
91 Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks
92 Axillary Surgery Approach Impacts BCRL Risk in Breast Cancer Patients
93 The long non-coding RNA PCAL7 promotes prostate cancer by strengthening androgen receptor signaling.
94 Medically Integrated Pharmacy Care Benefits Patients
95 ASCO Releases New Guidelines on PARP Inhibitor Use for Management of Ovarian Cancer
96 Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: A single-arm, open-label, repeat-dose clinical trial
97 Comparing Laparotomy versus Robotic-Assisted Interval Debulking Surgery for Patients with Advanced Epithelial Ovarian Cancer Receiving Neoadjuvant Chemotherapy
98 Immunotherapy treatment after chemotherapy significantly slows metastatic bladder cancer
99 Research in Review
100 Bolder, More Aggressive Steps are Needed to Reduce Disparities and Achieve Equity in Cancer Care